Purpose: The AccuBoost brachytherapy system applies HDR 192Ir beams peripherally to the breast using collimating applicators. The purpose of this study was to benchmark Monte Carlo simulations of the HDR 192Ir source, to dosimetrically characterize the round applicators using established Monte Carlo simulation and radiation measurement techniques and to gather data for clinical use.
Methods: Dosimetric measurements were performed in a polystyrene phantom, while simulations estimated dose in air, liquid water, polystyrene and ICRU 44 breast tissue. Dose distribution characterization of the 4-8 cm diameter collimators was performed using radiochromic EBT film and air ionization chambers.
Results: The central axis dose falloff was steeper for the 4 cm diameter applicator in comparison to the 8 cm diameter applicator, with surface to 3 cm depth-dose ratios of 3.65 and 2.44, respectively. These ratios did not considerably change when varying the phantom composition from breast tissue to polystyrene, phantom thickness from 4 to 8 cm, or phantom radius from 8 to 15 cm. Dose distributions on the central axis were fitted to sixth-order polynomials for clinical use in a hand calculation spreadsheet (i.e., nomogram). Dose uniformity within the useful applicator apertures decreased as depth-dose increased.
Conclusions: Monte Carlo benchmarking simulations of the HDR 192Ir source using the MCNP5 radiation transport code indicated agreement within 1% of the published results over the radial/angular region of interest. Changes in phantom size and radius did not cause noteworthy changes in the central axis depth-dose. Polynomial fit depth-dose curves provide a simple and accurate basis for a nomogram.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773456 | PMC |
| http://dx.doi.org/10.1118/1.3232001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
On the impact of improved dose calculation accuracy in clinical treatment planning for superficial high-dose-rate brachytherapy of extensive scalp lesions.
Phys Imaging Radiat Oncol
October 2024
Division of Medical Physics, Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, German Cancer Consortium (DKTK), Partner Site DKTK, Freiburg, Germany.
Article Synopsis
- TG-43 dose calculations in HDR brachytherapy often overlook variations in tissue density and scattering effects, leading to inaccuracies.
- Model-based dose calculation algorithms (MBDCAs) were introduced to enhance precision in high-dose-rate (HDR) treatments, especially for extended scalp lesions.
- This study found that MBDCAs provided more accurate dose estimations compared to TG-43, with discrepancies reduced to 2%-6% versus the 10%-23% overestimations seen with TG-43 at greater distances from the implant.
Dosimetric comparison of Acuros BV and AAPM TG-43 formalism for interstitial iridium-192 high-dose-rate brachytherapy.
J Contemp Brachytherapy
June 2024
Department of Medical Physics, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Purpose: The aim of this study was a retrospective dosimetric comparison of iridium-192 (Ir) high-dose-rate (HDR) interstitial brachytherapy plans using model-based dose calculation algorithm (MBDCA) following TG-186 recommendations and TG-43 dosimetry protocol for breast, head-and-neck, and lung patient cohorts, with various treatment concepts and prescriptions.
Material And Methods: In this study, 59 interstitial Ir HDR brachytherapy cases treated in our center (22 breast, 22 head and neck, and 15 lung) were retrospectively selected and re-calculated with TG-43 dosimetry protocol as well as with Acuros BV dose calculation algorithm, with dose to medium option based on computed tomography images. Treatment planning dose volume parameter differences were determined and their significance was assessed.
A comparison of TG-43 and TG-186 dose calculation algorithms for treatment planning of intra-cavitary brachytherapy using tandem and ovoid applicator.
J Contemp Brachytherapy
August 2024
Department of Radiation Oncology, Indraprastha Apollo Hospital, New Delhi, India.
Purpose: The present study evaluated the dosimetric impact and compared the dose variations between the advanced collapsed cone engine (Task Group 186) and Task Group 43 plans for cervical cancer using tandem and ovoid applicators.
Material And Methods: Thirty cervical cancer patients underwent iridium-192 (Ir) high-dose-rate (HDR) intra-cavitary brachytherapy using tandem and ovoid applicator. Original treatment plans for all patients were created using TG-43 dose calculation formalism.
3D technique in superficial brachytherapy: New attitude in old field of mycosis fungoides.
J Contemp Brachytherapy
August 2024
Department of Oncology and Radiotherapy, University Clinical Centre in Gdan,sk, Gdan,sk, Poland.
A case report of non-classical treatment choice for mycosis fungoides (MF) presented on the left upper eyelid and forehead. Superficial brachytherapy using 3D technique was prescribed to preserve the lens's functionality, and successfully eliminate malignant lesion. Treatment was conducted with high-dose-rate (HDR) brachytherapy using iridium-192 (Ir) source as a base and Flexitron device as an afterloader.
View Article and Find Full Text PDFBeam quality correction factors for dose measurements around Ir brachytherapy sources.
J Appl Clin Med Phys
January 2025
Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Purpose: To provide beam quality correction factors ( ) for detectors used in Ir brachytherapy dosimetry measurements.
Materials And Methods: Ten detectors were studied, including the PTW 30013 and Exrading12 Farmer large cavity chambers, seven medium (0.1-0.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!